A study to assess therapeutic equivalence between test EMLA patch with marketed EMLA patch in healthy subjects.

Trial Identifier: D069GC00001
Sponsor: AstraZeneca
Collaborator:
PAREXEL International GmbH
NCTID:: NCT03313336
Start Date: October 2017
Primary Completion Date: November 2017
Condition: Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
German Translation

Trial Locations

Country Location
Germany Berlin, Germany, 14050